Sorrento Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Sorrento Therapeutics, Inc.(2.6%)
Sorrento Therapeutics | 4:持股变动声明-股东 Sorrento Therapeutics, Inc.
Sorrento Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Sorrento Therapeutics, Inc.(1.3%)
Sorrento Therapeutics | 4:持股变动声明-股东 Sorrento Therapeutics, Inc.
Sorrento Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Sorrento Therapeutics, Inc.(43.3%)
Sorrento Therapeutics | 4:持股变动声明-高管 Ji Henry
Sorrento Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-STATE STREET CORPORATION(0.03%)
Sorrento Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(0.0%)
Sorrento Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Sorrento Therapeutics, Inc.(44.2%)
Sorrento Therapeutics | SC 13G:超过5%持股股东披露文件-Millennium Management LLC(3.1%),Millennium Group Management LLC(3.1%)等
Sorrento Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-STATE STREET CORPORATION(10.73%),SSGA FUNDS MANAGEMENT, INC.(8.78%)
Sorrento Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(6.26%)
Sorrento Therapeutics | 5:权益变更年度报表-董事 Janda Kim
Sorrento Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(8.4%)
Sorrento Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Sorrento Therapeutics, Inc.(45.5%)
Sorrento Therapeutics | 4:持股变动声明
Sorrento Therapeutics | 4:持股变动声明
Sorrento Therapeutics | 4:持股变动声明
Sorrento Therapeutics | 4:持股变动声明
Sorrento Therapeutics | 4:持股变动声明
暂无数据
暂无数据